Chuma Obineme, MD
Gastroenterology · Summerville, SCNPI 1386175552
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,200 of the $11,226 with a category attached, or 64.1%. Sanofi accounts for 79.5% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $8,870, 8.5 times the $1,039 reported in 2023.
Across 105 payments — averaging $106.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$9K
- AbbVie$664
- Phathom Pharmaceuticals, Inc.$249
- Inari Medical, Inc.$194
- Lilly USA, LLC$158
- Gilead$134
- plus $897 from 19 others
What the payments were for
- Consulting fees$7,20064%
- Travel & lodging$7126%
- Food & beverage$3,29729%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 17 | $8,929 |
| AbbVie | 34 | $664 |
| Phathom Pharmaceuticals, Inc. | 9 | $249 |
| Inari Medical, Inc. | 1 | $194 |
| Lilly USA, LLC | 3 | $158 |
| Gilead | 7 | $134 |
| Janssen Scientific Affairs, LLC | 1 | $122 |
| Pfizer | 6 | $109 |
| Medtronic | 2 | $95 |
| Johnson & Johnson | 6 | $88 |
| Atmo Biosciences Inc | 1 | $83 |
| Fujifilm Healthcare Americas Corporation | 1 | $75 |
| Daiichi Sankyo Inc. | 2 | $49 |
| Bristol Myers Squibb | 3 | $44 |
| Neuraxis, Inc. | 1 | $33 |
| Axonics, Inc. | 2 | $30 |
| Ferring Pharmaceuticals Inc. | 1 | $27 |
| Organon | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $19 |
| Shield Therapeutics Inc | 1 | $18 |
| Celltrion USA Inc. | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$363
- FLOWTRIEVER CATHETER, S$194
- CT THROMBECTOMY SYSTEM KIT$194
- VOQUEZNA$125
- Tremfya$122
- Skyrizi$114
How this compares
$11,226 in reported general payments places this provider in the 80th percentile of 259 gastroenterology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 71 | $1,643 |
| Lactulose | 97 | $740 |
| Dicyclomine Hcl | 29 | $645 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 15 | $244 |
| Famotidine | 12 | $161 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Summerville
- Brett van Leer GreenbergSummerville$45K
- Erin ForsterCharleston$788K
- Mark DeleggeCharleston$568K
- Nathan ShoresCharleston$217K
- Andre EaddyGreenville$212K
- Alejandro SuarezCharleston$210K
- Veeral OzaGreenville$199K
- Peter CottonCharleston$193K
- Christina BauerGreenville$179K
- Andrew PearsonMyrtle Beach$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.